The cardiovascular system

Omega-3 fatty acid therapy is a promising intervention for the secondary prevention of coronary artery disease (CAD)


Many studies support a strong role for omega-3 fatty acids derived from fish oil in secondary prevention through a presumptive role as an antiarrhythmic agent and through an ability to promote plaque stabilization. 

A large number of clinical trials studying the role of omega-3 fatty acids have been conducted in patients with CAD or prior myocardial infarction (MI) examining hard cardiovascular end points, including total mortality, cardiovascular mortality, sudden death, and nonfatal MI. Studies have shown up to 50% reduction of total mortality and sudden death in patients with implantable cardioverter defibrillators due to ischemic ventricular arrhythmias. A large study in Japan suggests significant benefits in the reduction of unstable angina and nonfatal coronary events. The total of evidence supports that Omega-3 fatty acid treatment in various dosage and length of time play a role in the outcome of patients with CAD.

Go back



Contact Lysi

Lýsi Ltd. - Fiskislóð 5-9 - 101 Reykjavík
Tel 525 8100 - Fax  562 3828


API/GMP Certification 
FSSC 22000 Certification
HACCP Certification
Halal Certification
Friends of the Sea Certification
Marine Stewardship Council Certification
Equal Pay Certification

Contact LYSI

LYSI hf.
Fiskislod 5-9
101 Reykjavik

Tel  + 354 525 8100
Fax + 354 562 3828

Terms and privacy policy

© 2014 - Lýsi hf.